Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
about
Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogeneAntibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine SecretionPhosphatase of regenerating liver: a novel target for cancer therapy.Molecular diagnosis of intrahepatic cholangiocarcinoma.Tissue-specific alterations of PRL-1 and PRL-2 expression in cancerUpregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinomaVEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinomaPrognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.Downregulation of phosphatase of regenerating liver-3 is involved in the inhibition of proliferation and apoptosis induced by emodin in the SGC-7901 human gastric carcinoma cell line.Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer.Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.Phosphatase of regenerating liver-3 induces angiogenesis by increasing extracellular signal-regulated kinase phosphorylation in endometrial adenocarcinoma.Overexpression of phosphatase regenerating liver 3 in oesophageal squamous cell carcinoma associated with metastasis and its comparison with phosphatase regenerating liver 1.Expression of Phosphatase Regenerating Liver-1 in Esophageal Squamous Cell Carcinoma Associated with Metastasis
P2860
Q27326713-546189EC-934A-49D9-A087-28B6E3F3C7DAQ28469321-376503DE-A839-4964-A5A2-03885385EBF9Q34437541-BB2380AE-AC95-4C11-BD2D-776220E32389Q35592221-103ACA6C-7514-4119-9022-DC1037BE9531Q35747480-284EFF0C-FDE7-4215-872C-5AF251F77EE3Q36484951-75B5BE4D-332D-4ADB-B14C-7446057A5019Q37158442-D6DF7266-6A1C-47AA-8A0D-2B12A9C65F15Q38148062-5BFA5423-82F1-4D2A-B297-A8B49F30A472Q38644355-44F72601-15E1-41D2-9407-731110AD42A1Q39280610-8FFC7F63-46F6-4E26-9304-3454629CD309Q40967704-226062B6-C98D-43E0-A637-56E9F9354F30Q47123783-AE7522DD-D359-49A7-BE75-8AFE31D0B3F1Q47672524-43C25735-DBFC-42C6-9E05-FA7957694253Q53171351-31BEE9B8-928C-4669-BD48-8753258193DCQ58689969-825527D4-5114-4B64-8BE4-806DD38E7959
P2860
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
@en
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
@nl
type
label
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
@en
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
@nl
prefLabel
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
@en
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
@nl
P2093
P2860
P1476
Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
@en
P2093
Chengyong Qin
Mingchen Zhu
Shuhong Zhang
P2860
P2888
P304
P356
10.1007/S12253-009-9200-Y
P577
2009-09-09T00:00:00Z